Medtronic (NYSE:MDT) announced today that it completed its previously announced acquisition of Scientia Vascular for $550 million. In March, the medtech giant said it struck a deal to acquire Salt Lake City, Utah–based Scientia, which develops access products for treating complex neurovascular conditions. With the acquisition, Medtronic … [Read more...] about Medtronic completes acquisition of Scientia Vascular
Business
Spectrum Vascular acquires catheter guidance tech developer Piccolo Medical
Spectrum Vascular announced today that it acquired catheter guidance product developer Piccolo Medical. White Plains, New York-based Spectrum Vascular said the acquisition deepens a partnership focused on bringing next-generation catheter guidance technology to the market. It said the move marks a significant step forward in its mission to … [Read more...] about Spectrum Vascular acquires catheter guidance tech developer Piccolo Medical
Advanced NanoTherapies raises $31M for drug-coated balloon tech
Advanced NanoTherapies announced that it closed an oversubscribed Series B financing worth more than $31 million. An undisclosed strategic investor, along with S3 Ventures, co-led the round. The T45 Fund and new and existing investors also participated. Funding adds to $4 million raised in 2023. The funds support the company's therapies for … [Read more...] about Advanced NanoTherapies raises $31M for drug-coated balloon tech
Johnson & Johnson CMO explains advances behind ‘game-changer’ Shockwave C2 Aero catheter
With its $13 billion acquisition of Shockwave Medical in 2024, Johnson & Johnson added the market leader in intravascular lithotripsy (IVL) to its portfolio. Since then, the company has continued to build on that leadership position with new product rollouts. That includes the recent launch of Shockwave C2 Aero, the latest catheter system … [Read more...] about Johnson & Johnson CMO explains advances behind ‘game-changer’ Shockwave C2 Aero catheter
Olympus to acquire urologic balloon spacer maker BioProtect for $270M
Olympus announced today that it entered into a definitive agreement to acquire urologic medical device manufacturer BioProtect. The deal includes a value of $270 million, with certain amounts held in escrow for a period dependent on uninterrupted business operation. Tokyo-based Olympus expects to complete the deal by the end of the second … [Read more...] about Olympus to acquire urologic balloon spacer maker BioProtect for $270M
Endologix acquires Pounce thrombectomy system from Surmodics
Endologix announced today that it acquired the Pounce thrombectomy system from Surmodics, closing the deal on May 18. Pounce, an FDA-cleared and commercially available fully mechanical thrombectomy platform, offers the non-surgical removal of thrombi and emboli from peripheral arteries. It comes in multiple configurations to support use across a … [Read more...] about Endologix acquires Pounce thrombectomy system from Surmodics
Cagent Vascular reports first-in-human IVL cases, closes $41M Series D
Cagent Vascular today announced the first-in-human cases with its Serranator Sonic IVL system alongside significant funding. In addition to the first human use of the intravascular lithotripsy (IVL) system, the company closed a $41 million Series D round. Serranator Sonic IVL's first human procedures took place in Uzbekistan as part of its … [Read more...] about Cagent Vascular reports first-in-human IVL cases, closes $41M Series D
Artivion closes $175M acquisition of aortic arch maker Endospan
Endospan announced today that Artivion completed its $175 million acquisition of the company, following FDA approval for its Nexus system. The FDA granted premarket approval (PMA) for the Nexus aortic arch system last month. Nexus treats aortic arch disease, including chronic aortic dissections, in patients at high risk for open surgical repair. … [Read more...] about Artivion closes $175M acquisition of aortic arch maker Endospan
Rivermark Medical brings in $20M to support FloStent device for BPH
Andera Partners said today that it led a $20 million Series D financing round for urology-focused medical device maker Rivermark Medical. Rivermark Medical aims to redefine the treatment of benign prostatic hyperplasia (BPH) through its FloStent platform. It also picked up funding in the Series D from existing investors and an unnamed strategic … [Read more...] about Rivermark Medical brings in $20M to support FloStent device for BPH
Stryker completes acquisition of Amplitude Vascular Systems
Stryker (NYSE:SYK) announced today that it completed its acquisition of Amplitude Vascular Systems (AVS) for an undisclosed amount. AVS develops an intravascular lithotripsy (IVL) platform designed to treat calcified peripheral arterial disease (PAD). It uses pulsed CO₂-generated pressure waves delivered uniformly through an IVL balloon … [Read more...] about Stryker completes acquisition of Amplitude Vascular Systems
